Windingoudi Rimwagna Christian Ouédraogo | Pharmacology | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Windingoudi Rimwagna Christian Ouédraogo — Institut de Recherche en Sciences de la Santé, Burkina Faso.

Windingoudi Rimwagna Christian Ouédraogo
Affiliation Institut de Recherche en Sciences de la Santé
Country Burkina Faso
Scopus ID 58145355200
Documents 4
Citations 10
h-index 1
Subject Area Pharmacology
Event Scientific World Research Awards
ORCID 0000-0001-8365-5579

Windingoudi Rimwagna Christian Ouédraogo is a pharmacology researcher. His documented research activities include pharmacological investigations of medicinal plants, natural products, cardiovascular effects, and experimental models of disease.[1]

Abstract

This profile presents the research activities and scholarly publications of Windingoudi Rimwagna Christian Ouédraogo, whose work focuses on pharmacology and medicinal plant research. His documented publications investigate plant-derived extracts, biological activity, toxicity, vascular protection, and potential therapeutic applications.[1]

Keywords

Pharmacology, medicinal plants, natural products, phytochemistry, cardiovascular research, antihypertensive activity, antioxidant activity, toxicity assessment, vascular endothelium, and drug discovery.

Introduction

Pharmacological research examines the biological effects of substances and their potential therapeutic applications. Research into medicinal plants contributes experimental evidence concerning chemical constituents, safety, and biological activity. Ouédraogo’s listed publications reflect these themes through investigations involving plant extracts and experimental cardiovascular models. [2]

Research Profile

According to his research record, Ouédraogo has worked as a Pharmacology Research Engineer at the Institut de Recherche en Sciences de la Santé since December 2019. His recorded keywords include pharmacology, phytochemistry, natural products, medicinal plants, and life and human sciences. [1]

Research Contributions

His studies investigate the pharmacological properties of plant extracts, including potential antihypertensive, antioxidant, and vascular protective effects. Other publications examine acute toxicity, phytochemical profiles, and experimental therapeutic effects. These studies contribute to the scientific investigation of natural products without, by themselves, establishing clinical efficacy in humans. [3]

Publications

The ORCID record lists six works, including studies published in 2023, 2024, 2025, and 2026. Examples include research on Phaseolus vulgaris extracts and vascular protection, Flemingia faginea phenolic compounds, and the pharmacological effects of Ampelocissus africana. The record covers the associated journals and DOIs for the publications. [1]

Research Impact

The bibliometric figures are four documents, ten citations, and an h-index of one. These figures are profile data and should be checked against the current Scopus record before formal publication. Citation counts and h-index values describe selected aspects of scholarly output but do not independently establish research quality or practical impact. [4]

Award Suitability

The Best Researcher Award category may recognize contributions to scientific investigation, publication, collaboration, and disciplinary development. Ouédraogo’s documented pharmacology publications provide material for consideration within this category. Eligibility and final award decisions should follow the official event criteria and independent verification of the researcher’s achievements. [5]

Conclusion

Windingoudi Rimwagna Christian Ouédraogo’s recorded research focuses on pharmacology, medicinal plants, and the investigation of biologically active natural products. His published studies provide verifiable starting points for evaluating his academic profile. Recognition should be based on documented achievements and the award organizer’s published assessment criteria.

References

  1. ORCID. (n.d.). Windingoudi Rimwagna Christian Ouédraogo: Researcher record and works. ORCID.
    https://orcid.org/0000-0001-8365-5579
  2. Ouédraogo, W. R. C., et al. (2026). Antihypertensive and Vascular Endothelium Protection Effect of the Ethyl Acetate Fraction of Phaseolus vulgaris Pods in L-NAME-induced Hypertensive Mice. Biomedical & Pharmacology Journal.
    https://doi.org/10.13005/bpj/3524
  3. Ouédraogo, W. R. C., et al. (2026). Evaluation of organic acids, cytotoxicity, oral acute toxicity and diuretic effect of Phaseolus vulgaris crops ethyl acetate extract for cardiovascular health improvement. Journal of Drug Delivery and Therapeutics.
    https://doi.org/10.22270/jddt.v16i5.7765
  4. Elsevier. (n.d.). Scopus author details: Windingoudi Rimwagna Christian Ouédraogo, Author ID 58145355200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58145355200
  5. Scientific World Research Awards. (n.d.). Official award website.
    https://scientificworld.net/

Thomas Birngruber | Pharmacokinetics | Best Industrial Research Award

Published on by Scientific World Research Awards

Best Industrial Research Award

Thomas Birngruber — JOANNEUM RESEARCH HEALTH, Austria.

Thomas Birngruber
Affiliation JOANNEUM RESEARCH HEALTH
Country Austria
Scopus ID 36569938300
Documents 57
Citations 1,209
h-index 18
Subject Area Pharmacokinetics
Event Scientific World Research Awards
ORCID 0000-0001-8827-4660

Thomas Birngruber is a researcher, whose research publication record includes studies addressing dermal, cerebral, and interstitial pharmacokinetic measurements and pharmaceutical delivery systems. His ORCID record identifies and documented a research portfolio containing pharmaceutical and biomedical studies. [1]

Abstract

Thomas Birngruber’s documented research profile is centered on pharmacokinetics, drug delivery, open flow microperfusion and related biomedical applications. Research profile focused on pharmacokinetics and associated pharmaceutical research methodologies. His ORCID record lists publications addressing dermal, cerebral and interstitial pharmacokinetic measurements, topical formulations and therapeutic agents. [2]

Keywords

Pharmacokinetics; open flow microperfusion; dermal drug delivery; topical pharmaceuticals; bioequivalence; cerebral microperfusion; drug transport; interstitial fluid; pharmaceutical research.

Introduction

The publication record associated with Birngruber includes studies spanning pharmaceutical sciences and biomedical research, with recurring attention to methods for measuring drug concentrations in biological tissues. Birngruber’s documented works apply experimental microperfusion approaches to investigate drug concentrations in skin, brain, and other interstitial compartments.[3]

Research Profile

The Research subject area is pharmacokinetics, while the documented works show particular activity in dermal pharmacokinetics, open flow microperfusion and topical drug research. Recent records include investigations of systemic redistribution, cutaneous bioequivalence and local drug concentrations.The profile also includes collaborative publications in pharmaceutical sciences, biomedical research, and drug-development applications.[4]

Research Contributions

Representative contributions include research using open flow microperfusion to investigate topical drug delivery, dermal pharmacokinetics, cerebral drug transport and interstitial-fluid measurements. The research record also includes collaborative studies involving advanced pharmaceutical formulations and therapeutic antibodies. [5]

Publications

The Research record reports the works displayed in its publication interface and includes recent articles such as a 2026 European Journal of Pharmaceutical Sciences study on cutaneous pharmacokinetic-based bioequivalence and a 2025 Journal of Controlled Release study concerning subcutaneous bioavailability of monoclonal antibodies. [2]

Research Impact

The researcher profile reports 57 documents, 1,209 citations and an h-index of 18. These quantitative indicators are presented as profile for the recognition article. These bibliometric figures provide quantitative indicators of publication and citation activity associated with the researcher profile. His documented  research portfolio containing pharmaceutical and biomedical studies.[1]

Award Suitability

For the Scientific World Research Awards, the nomination information identifies the recognition category as Best Industrial Research Award and the subject area as Pharmacokinetics. The documented publication portfolio provides a research basis for describing work in pharmaceutical and biomedical research without assigning claims beyond the record

Conclusion

Thomas Birngruber’s documented profile combines pharmacokinetic research with methodological work involving open flow microperfusion, drug delivery and tissue-level measurement. The ORCID record provides identifiable employment and publication information, while the supplied bibliometric data summarize the research profile presented for this award article.[1]

References

  1. ORCID. (2026). Thomas Birngruber, ORCID iD 0000-0001-8827-4660. ORCID.
    https://orcid.org/0000-0001-8827-4660
  2. Crossref. (2026). The Impact of Systemic Redistribution on Cutaneous Pharmacokinetic-Based Bioequivalence. European Journal of Pharmaceutical Sciences.
    https://doi.org/10.1016/j.ejps.2026.107673
  3. Elsevier. (2025). Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model. Journal of Controlled Release.
    https://doi.org/10.1016/j.jconrel.2025.114401
  4. Elsevier. (2024). Cutaneous pharmacokinetics-based bioequivalence: A clinical dermal open flow microperfusion verification study. European Journal of Pharmaceutical Sciences.
    https://doi.org/10.1016/j.ejps.2024.106827
  5. Elsevier. (2023). Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion. International Journal of Pharmaceutics.
    https://doi.org/10.1016/j.ijpharm.2023.123269